ERCC6 and glioblastoma: In addition, we find that the PMS1/PMS2 and RAD23A/ERCC6 mRNA ratios, indicative of MutLβ/MutLα and of global/translation NER ratios respectively, to be independent risk factors in this GBM patient population.